Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on May 5, 2025
NextStep Genetics Launches in DFW Offering Compassionate, Court-Admissible DNA Testing
EIN Presswire
·
May 5, 2025
GARLAND, TX, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- NextStep Genetics Launches in Dallas–Fort Worth: Bringing Compassionate, Court-Admissible DNA Testing to Local Families and Legal Professionals NextStep Genetics, a locally owned and …
Consilium Staffing Introduces Concierge Departments to Enhance Provider Experience
EIN Presswire
·
May 5, 2025
A leader in locum tenens, Consilium Staffing announces the creation of two specialized departments: The Travel Concierge and The Payment Concierge. IRVING, TX, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- A leader in locum tenens, Consilium Staffing …
EmerVax Co-Founder and Scientific Advisor Dr. Mariano García-Blanco Elected to the National Academy of Sciences
EIN Presswire
·
May 5, 2025
Election recognizes internationally respected molecular biologist for distinguished contributions to RNA biology HOUSTON, TX, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- EmerVax, a biotechnology company developing circular RNA-based therapeutics, …
Ntirety Unveils New Nutanix Private Cloud in Their Managed Private Cloud Portfolio
EIN Presswire
·
May 5, 2025
Ntirety launches a refreshed Ntirety Private Cloud offering with a new Nutanix cloud to support growing hybrid cloud needs. AUSTIN, TX, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- The demand for private cloud continues to expand and organizations …
Vintage Park Lands Experiential Wellness Studio Featuring Float Therapy, Cold Plunge, Sauna, Red Light & More
EIN Presswire
·
May 5, 2025
Immersive wellness is coming to Vintage Park—featuring float therapy, cold plunge, sauna, red light, and more to help you reset, recover, and recharge. HOUSTON, TX, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Altered States Wellness, a Dallas-based …
Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company
GlobeNewswire
·
May 5, 2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has …
Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results
GlobeNewswire
·
May 5, 2025
EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8: …
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
GlobeNewswire
·
May 5, 2025
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the …
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference
GlobeNewswire
·
May 5, 2025
BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at …
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
GlobeNewswire
·
May 5, 2025
Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced …
DBV Technologies participera à la conférence Citizens JMP Life Sciences
GlobeNewswire
·
May 5, 2025
Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique en phase clinique, …
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 5, 2025
MALVERN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …
Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 5, 2025
Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the first week of June Initial Phase 2 data for rosnilimab in …
Certara Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 5, 2025
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First Quarter Highlights: Revenue was $106.0 …
SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance
GlobeNewswire
·
May 5, 2025
First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9% U.S. revenue of $44.8 million, representing growth of 26.6% Gross margin of 79.7%, representing an …
Castle Biosciences Reports First Quarter 2025 Results
GlobeNewswire
·
May 5, 2025
Q1 2025 revenue increased 21% over Q1 2024 to $88 million Q1 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, DecisionDx®-SCC, TissueCypher®) increased 33% over Q1 2024 Raising full-year 2025 revenue guidance to $287-297 million …
Context Therapeutics Announces Chief Medical Officer Transition
GlobeNewswire
·
May 5, 2025
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
May 5, 2025
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …
Castle Biosciences to Acquire Previse
GlobeNewswire
·
May 5, 2025
Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development FRIENDSWOOD, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- …
Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025
GlobeNewswire
·
May 5, 2025
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …